SCHEMBL3433366

SCHEMBL3433366

Nc1cc(CN2CCS(=O)(=O)CC2)cc2cc(-c3ccccc3)[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 1/20 0.40
DHODH Q02127 2/20 0.39
LMNA P02545 2/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 1/20 0.39
VCP P55072 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPY5R Q15761 2/20 0.37
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
SLC2A1 P11166 1/20 0.36
FAAH O00519 1/20 0.36
KDM4E B2RXH2 1/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ACP1 P24666 1/20 0.35
PPARG P37231 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29384916 1.00 JAK1 (0.40) JAK1DHODHLMNAKMT2AMEN1
SCHEMBL25924580 0.86 JAK2 (0.44) JAK1DHODHKMT2AMEN1NPY5R
SCHEMBL27182356 0.84 L3MBTL1 (0.40) KMT2AMEN1NPY5RKDM4EALDH1A1
SCHEMBL3011386 0.83 ALDH1A1 (0.43) JAK1DHODHKDM4EALDH1A1ACP1
SCHEMBL2999222 0.83 DHODH (0.39) DHODHLMNAKMT2AMEN1VCP
SCHEMBL2995348 0.79 VCP (0.35) JAK1DHODHLMNAKMT2AMEN1
SCHEMBL3415437 0.78 VCP (0.40) DHODHKMT2AMEN1VCPCYP2C19
SCHEMBL29386984 0.77 CSF1R (0.42) DHODHVCPNPY5RDRD2DRD4
SCHEMBL1897623 0.77 CSF1R (0.42) DHODHVCPNPY5RDRD2DRD4
SCHEMBL3014664 0.77 DHODH (0.38) DHODHLMNAVCPNPY5RDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114080382-B Process for preparing indole or indazole compounds 株式会社LG化学 2024-05-24 CN claimed
EP-3971184-B1 METHOD FOR PREPARING INDOLE OR INDAZOLE COMPOUND LG CHEMICAL LTD (KR) 2024-04-03 EP claimed
EP-3971184-A1 METHOD FOR PREPARING INDOLE OR INDAZOLE COMPOUND LG Chem, Ltd. (KR) 2022-03-23 EP claimed
CN-114080382-A Process for preparing indole or indazole compounds 株式会社LG化学 2022-02-22 CN claimed
WO-2020256429-A1 METHOD FOR PREPARING INDOLE OR INDAZOLE COMPOUND 주식회사 엘지화학 2020-12-24 WO claimed
CN-114080386-B Process for preparing indole or indazole compounds 株式会社LG化学 2024-05-31 CN disclosed
CN-114080382-B Process for preparing indole or indazole compounds 株式会社LG化学 2024-05-24 CN disclosed
EP-3971185-B1 METHOD FOR PREPARING INDOLE OR INDAZOLE COMPOUND LG CHEMICAL LTD (KR) 2024-04-17 EP disclosed
EP-3971184-B1 METHOD FOR PREPARING INDOLE OR INDAZOLE COMPOUND LG CHEMICAL LTD (KR) 2024-04-03 EP disclosed
CN-114096534-B Process for preparing indole or indazole compounds 株式会社LG化学 2024-01-02 CN disclosed
EP-3971186-B1 PREPARATION METHOD FOR INDOLE OR INDAZOLE COMPOUND LG CHEMICAL LTD (KR) 2023-08-02 EP disclosed
EP-3971186-A1 PREPARATION METHOD FOR INDOLE OR INDAZOLE COMPOUND LG Chem, Ltd. (KR) 2022-03-23 EP disclosed
WO-2020256429-A1 METHOD FOR PREPARING INDOLE OR INDAZOLE COMPOUND 주식회사 엘지화학 2020-12-24 WO disclosed
WO-2020256432-A1 METHOD FOR PREPARING INDOLE OR INDAZOLE COMPOUND 주식회사 엘지화학 2020-12-24 WO disclosed
WO-2020256437-A1 PREPARATION METHOD FOR INDOLE OR INDAZOLE COMPOUND 주식회사 엘지화학 2020-12-24 WO disclosed
EP-2230238-B1 INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT LG LIFE SCIENCES LTD (KR) 2013-12-11 EP disclosed
US-8349885-B2 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect LG LIFE SCIENCES LTD. (KR) 2013-01-08 US disclosed
US-20120270203-A1 INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT LG CHEM, LTD. (KR) 2012-10-25 US disclosed
US-20100291533-A1 INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT LG LIFE SCIENCES LTD. (KR) 2010-11-18 US disclosed
EP-2230238-A2 INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT LG Life Sciences Ltd. (KR) 2010-09-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270203-A1 INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT IDO1, IDO2, INMT JAK1 279/4885DHODH 2870/4885LMNA 1945/4885
US-20100291533-A1 INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT IDO1, IDO2, INMT JAK1 279/4885DHODH 2870/4885LMNA 1945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.